Lys-SMCC-DM1 is an antibody-drug conjugate (ADC) designed to target HER2, delivering the potent microtubule-disrupting agent DM1. It is widely utilized in breast cancer research for investigating ADC mechanisms and efficacy in both cellular (in vitro) and animal (in vivo) experimental models.
Molekulargewicht:
1103.71
Reinheit:
98% (May vary between batches)
CAS Nummer:
[1281816-04-3]
Formel:
C53H75ClN6O15S
Target-Kategorie:
Drug-Linker Conjugates for ADC,Microtubule Associated